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 The molting hormone, 20-hydroxyecdysone (20E), orchestrates Drosophila 
development through the actions of the ecdysteroid receptor, which is a heterodimer of 
two members of the nuclear hormone receptor superfamily, EcR and Ultraspiracle (USP). 
The EcR/USP heterodimer mediates ecdysteroid response by inducing or repressing the 
expression of target genes. In this study a chimeric USP whose ligand binding domain 
(LBD) was replaced by that of a Chironomus LBD was used to test ecdysteroid 
responsiveness in vitro and in vivo. This was done to determine if the late larval lethality 
observed in d/cusp mutant flies is a result of the EcR/d/cUSP heterodimer’s inability to 
mediate 20E response. The chimeric USP had transcriptional capabilities comparable to 
those of Drosophila USP with all three DmEcR isoforms in vitro, while the ∆DBD 
versions of the chimeric USP and CtUSP constructs did not show the 20E-inducibility 
with DmEcRB1 that is seen with DmUSP ∆DBD (Beatty et al., 2006). RT-PCR was used 
to test the ability of EcR/d/cUSP to induce the expression of the 20E-regulated genes, 
E74A, E74B and BRC-Z1 in larval salivary glands. The expression level of these genes 
in mutant salivary glands was comparable to the levels seen in salivary glands extracted 
from wild-type animals. These results suggest the chimeric USP phenotype is not the 
result of impairment of 20E-inducibility, and that USP may have some function outside 
its classically understood role as the heterodimeric partner of EcR. 
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CHAPTER I 
INTRODUCTION 
 
Background 
Steroid hormones initiate changes in gene transcription that lead to cellular 
changes and ultimately, changes in whole organisms. Many of these responses occur via 
nuclear hormone receptors. In Drosophila, 20-hydroxyecdysone (20E) orchestrates these 
complex physiological changes in distinct phases of development through the actions of 
the ecdysteroid receptor. The molting hormone, 20E, is produced from its precursor, 
ecdysone, which is the primary steroid product of the ring gland. The functional 
ecdysteroid receptor is a heterodimer of EcR and Ultraspiracle (USP), which responds to 
the varying levels of 20E in developing Drosophila by inducing or repressing the 
expression of target genes (Yao et al., 1993).  
Nuclear hormone receptor structure 
EcR and USP are both members of the nuclear hormone receptor superfamily and 
as such contain distinct functional domains (designated A through F). The A/B domain is 
the N-terminal region and is variable in length among different nuclear receptors and 
among isoforms of the same receptor. This domain interacts with proteins involved in 
transcription and is capable of some ligand independent transcriptional capabilities 
(activation function-1; AF-1). It has also been shown to have an effect on ligand 
dependent activation function (AF-2). For instance, a receptor with multiple isoforms that 
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differ only in its N-terminal domain can show different levels of response to hormone  
(Beatty et al., 2006, Hu et al., 2003). The C domain or DNA binding domain (DBD) is a 
highly conserved region that contains two cysteine-cysteine zinc fingers. This domain 
defines a protein as a member of the nuclear receptor superfamily and is responsible for 
recognition of a specific hormone response element (HRE). The D domain or hinge 
region has been implicated in nuclear localization and response element recognition. The 
E domain or ligand binding domain (LBD) has a ligand dependent activation function 
(AF-2) and dimerization interface with other nuclear receptors. The LBD is composed of 
twelve α-helices that form a ligand binding pocket. Some nuclear receptors have C-
terminal F domains, but they are variable and it is unclear what their function is. Loss of 
this region in DmEcR has no effect on transcriptional capability (Hu et al.,2003). The 
EcR/USP heterodimer is stabilized by 20E allowing it to bind to ecdysone response 
elements (EcREs) within the promoter regions of genes. It has the highest affinity for a 
palindromic inverted repeat sequences separated by a single nucleotide characterized by 
the hsp27 EcRE, but it can also recognize direct repeats separated by one to five 
nucleotides (Vogtli et al., 1998). 
Genetic response to 20E 
Ecdysone concentrations fluctuate throughout development with the first peak 
occurring during embryogenesis. This is followed by smaller peaks at the first and second 
larval instars with only moderate variation during the third instar (Richards 1981, 
Handler 1982). There is a high peak prior to pupariation and the largest pulse of 
ecdysone, which is converted to 20E, occurs during metamorphosis to the adult stage 
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(Andres et al., 1993). These peaks trigger signal cascades that reorganize tissues and 
various concentrations of 20E are associated with different sets of genes. Ashburner’s 
observations of polytene chromosomes in larval salivary glands of Drosophila 
melanogaster led him to develop a model to explain the capability of 20E to induce such 
complex and varied genetic responses during development (Ashburner, 1974). He 
suggested that 20E induces the expression of a set of early genes that begin to regress 
after approximately three hours. At this point a larger set of late genes is induced. Based 
on in vitro studies of salivary glands treated with 20E and the protein synthesis inhibitor 
cyclohexamide, Ashburner showed that early gene expression was not affected, but that 
blockage of protein synthesis prevents late gene expression and the normal regression of 
early genes. This indicated that the protein products of early genes were regulating the 
expression of late genes. It also showed that the products of at least some of the 20E-
inducible genes were repressing the expression of early genes. When 20E was removed 
from the cultured glands there was an immediate regression in early gene expression 
while a subset of late genes were prematurely induced. This revealed another aspect of 
20E regulated gene expression through the repression of certain late genes.  
Another form of temporal regulation can be seen in the structure of the early 
genes E74, E75 and Broad-Complex (BR-C) all three of which encode DNA binding 
proteins. These genes are much longer than an average gene (>50kb), and all encode 
multiple isoforms through differential splicing and/or alternate 20E inducible promoters 
within the gene (Karim and Thummel, 1991). The alternate promoters within these early 
genes respond to different concentrations of 20E, which introduces another level of 
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regulation in response to 20E (Figure 1). Based on this sensitivity the early gene 
transcripts can be divided into two classes; class I transcripts that respond to low doses of 
20E (~2 x 10-9 M) and class II that respond to higher concentrations (~1 x 10-8 M) (Karim 
and Thummel, 1992). Class I mRNAs such as E74B and EcR are also defined by their 
regression as 20E titers increase, while E74A, E75A and E75B of Class II do not regress 
with additional 20E. BR-C, the largest of the early genes  (>100kb), expresses four main 
isoforms (Z1-Z4) with a total of 12 transcripts or more (Dibello et al., 1991). It has a 
complex expression pattern responding to a wide range of 20E concentrations that could 
indicate both Class I and Class II promoters within the gene (Karim and Thummel, 1992). 
In the salivary gland, BRC-Z1 is predominantly expressed and is necessary for glue gene 
production and the normal degeneration of the salivary gland prior to metamorphosis 
(Restifo and White, 1992; Costantino et al., 2008). 
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As mentioned above, EcR is the product of an early gene and begins to 
accumulate at low doses of ecdysone. It is one of two Drosophila nuclear hormone 
receptors that has a known ligand and three isoforms exist (A, B1 and B2) that differ only 
in their N-terminal domain. EcR A and the B isoforms arise through different promoters, 
while B1 and B2 are generated through differential splicing (Talbot et al., 1993). In vivo 
studies with mutant EcR isoforms have shown that different phenotypes result from 
mutations in specific isoforms indicating tissue and stage specific functions of EcR A, B1 
and B2 (Bender et al., 1997). EcRA expression predominates in tissues that develop 
through metamorphosis and become part of adult structures such as the imaginal discs 
and prothoracic gland cells. EcRB1 tends to be expressed in greater concentrations in 
larval tissues that degenerate during metamorphosis. In vitro studies have shown that 
EcRA may have an inhibitory function in its A/B domain that is not found in EcRB1 or 
EcRB2 (Mouillet et al., 2001).  
 
USP in development 
 
USP is necessary for multiple stages of development including embryogenesis, larval 
development and pupation and seems to play a distinct role in morphogenesis (Hall and 
Thummel 1998, Henrich et al., 2000), though its expression varies only modestly 
throughout development. This variability in function could be attributed to variant 
interactions between USP and multiple EcR isoforms or the ability of USP to form 
heterodimers with other nuclear receptor partners such as DHR38 and Sevenup (SVP) 
(Zehlhof et al., 1995, Sutherland et al., 1995, Baker et al., 2003).  
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USP has been classified as an orphan receptor because it has no undisputed ligand, 
although recently it has been proposed as the receptor for methyl farnesoate (Jones et al., 
2006). Methyl farnesoate is one of three hormones produced by the ring gland (including 
methyl epoxyfarnesoate and juvenile hormone III bis-epoxide) involved in regulating 
development, and mutant animals in which farnesoid synthesis is blocked with RNAi 
shows some phenotypic similarities to USP mutant animals (Jones et al., 2009).  
USP has a large ligand-binding cavity caused by a loop between helices 1 and 3 that is 
atypical of both nuclear receptor LBDs in general and USP in other insects. This loop 
also affects the conformation of the USP LBD by holding Helix 12 in a position that 
resembles a nuclear receptor bound to an antagonist (Clayton et al., 2001). A 
phospholipid is found within the ligand binding pocket of USP after crystallization of 
USP. It partially fills the ligand cavity and contributes to this inactive conformation 
(Billas et al., 2001). When Helix 12 is removed, the EcR/USP heterodimer is no longer 
able to bind DNA or activate transcription, and it interferes with EcR’s ability to bind 
hormone (Przibilla et al., 2004). Recently it has been shown that 20E can induce a 
transcriptional response in the salivary glands of mid-third instar larvae in the absence of 
USP, although it is not certain whether EcR is forming homodimers or heterodimers with 
another receptor (Costantino et al., 2008). 
 Not only is USP required for the normal activation of most 20E-inducible genes 
in the presence of hormone, it is also necessary for the repression of certain genes in the 
absence of 20E. In differentiating cells, such as sensory neurons and eye discs, it has been 
shown that the absence of USP causes the premature expression of BRC-Z1 which 
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normally appears at mid-third instar. The development of these mutant usp tissues 
resembles that of normal imaginal tissues treated with 20E, suggesting that the normal 
function of USP is repressive in these cells at this time (Schubiger and Truman, 2000; 
Gheish and McKeown, 2002; Schubiger et al., 2005). 
 
 Drosophila/Chironomus chimeric USP 
 
The midge (Chironomus tentans), like Drosophila, is a Dipteran and shares a 
similar pattern of development with an additional larval-larval molt before 
metamorphosis. The ecdysteroid receptor in Chironomus tentans is also composed of 
EcR and USP, but unlike Drosophila, midges express only one EcR isoform with two 
USP forms that differ in their N-terminal region. The Ctusp gene has been localized to a 
late ecdysone-induced puff in the Chironomus salivary gland suggesting a single gene 
that is alternately spliced into CtUSP-1 or 2 (Vögtli et al., 1999). The DBD of CtUSP 
shares almost 100% similarity to DmUSP. The LBD is less highly conserved but 
nonetheless shows much sequence similarity through the first 11 helices. The major 
differences lie in the two glycine rich regions that appear only in Drosophila USP before 
the first helix and in between helices 5 and 6. Helix 12 shows almost no similarity 
between the two USP sequences, except for a glutamic acid in the middle of the helix. 
This acidic residue has been implicated in AF-2 function in the USP homolog RXR 
(Westin et al., 1998; Vogtli et al., 1999).  
 The CtEcR isoform has been shown to be inactive or to have repressive function 
in cell culture similar to that of DmEcRA. Both CtUSP forms appear to heterodimerize 
equivalently with CtEcR and there is no apparent difference in their ability to bind DNA. 
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Both forms with CtEcR are also able to bind ligand (ponasterone A) with CtUSP-2 
showing 2.5 fold higher affinity, but unlike DmEcR, CtEcR in the absence of CtUSP was 
unable to bind detectably to ligand. The Chironomus ecdysone receptor was also tested 
with non-steroidal ecdysone agonists (Smagghe et al., 2002). These studies showed that 
the CtUSP/CtEcR complex has greater affinity to these agonists than the Drosophila 
ecdysone receptor. 
An ultraspiracle gene was cloned into a fly transformation vector that contained 
the Drosophila 5’ untranslated region (UTR) and DNA-binding domain with a repeat 
polylinker region connected to the Chironomus ligand-binding domain (Henrich et al., 
2000). By exchanging the LBDs of two related species, a chimeric ‘mutation’ is created 
and specific functions can be investigated within the LBD. The T-box is an element of 10 
amino acids downstream from the second zinc finger and depending on the source, can be 
considered part of the DBD or hinge (D) domain. It has been implicated in response 
element recognition and contact with the minor groove of the DNA helix. The T-box 
amino acid sequence for Drosophila and Chironomous USP is identical 
(KREAVQEERQRG), and an unanticipated additional ‘mutation’ arose during the 
cloning process that led to a duplication of part of the T-box (EAVQEER) and a 
polylinker sequence (RSP) between them.  
This chimeric USP was cloned into a transformation vector (pMVZ18; Figure 3), 
flies were transformed with the chimeric USP (d/cUSP), and the transgene tested in larval 
rescue studies with usp2, usp3 and usp4 mutant fly lines. These usp mutations contain 
amino acid substitutions in the DBD and all cause early larval death (Oro et al., 1990, 
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Henrich et al., 1994). In a wild-type background the chimeric USP does not affect 
development, which means that it is not interfering with normal USP activity. A single 
dose of d/cUSP is able to rescue usp mutants through larval development until a sudden 
arrest occurs at the late third instar. Prior to this arrest, the full-sized larvae failed to 
wander off the food and become motionless. Multiple doses of the chimeric USP are able 
to rescue some lines through adulthood, but in all cases the mutant larvae fail to contract, 
do not evert their anterior spiracles, and have incomplete cuticular tanning.  
To rule out the possibility that the chimeric USP phenotype was the result of an 
unrelated issue, follow up experiments were performed to further characterize the basis 
for the d/cUSP lethality. Western blots showed chimeric USP protein levels comparable 
to those of wild-type, so the phenotype is not caused by low USP expression. 
Electrophoretic mobility shift assays (EMSAs) were used to test the chimera’s ability to 
interact with Drosophila EcR (A and B1) and a palindromic and a direct repeat response 
element (DR3). These results indicate that d/cUSP and wild-type USP have very similar 
behavior when tested with DmEcR A and B1 and an ecdysone response element. Finally, 
ligand-binding studies were done with ponasterone A to compare the affinity of 
heterodimers of the chimeric USP, wild-type USP and Chironomus USP with DmEcR B1 
for this ligand. All of the heterodimers appear to have a similar affinity to ponasterone A, 
suggesting the chimeric USP does not interfere with the receptor’s ability to mediate 
ecdysteroid response.  
The phenotypes resulting from the expression of a chimeric USP in usp mutant 
flies were very similar to those found when usp mutants were rescued through the early 
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larval lethal stage with the addition of usp fused to a heat-inducible promoter, and results 
in larvae that lack USP at metamorphosis (Hall and Thummel, 1998). As noted with the 
chimeric USP, the larvae failed to wander off their food and experienced a ‘stationary 
stage’ prior to arrest. There was a failure to evert anterior spiracles and abnormalities in 
cuticle development, as well as incomplete prepupal contraction. Interestingly, these USP 
mutant phenotypes are comparable to those found with EcRB mutant flies which fail to 
wander normally and contract, and also reach a lethal stationary phase. EcRB1 mutants at 
this stage show an abnormal response to ecdysone affecting the transcription of some 
early genes such as BR-C, E74 and E75 (Bender et al., 1997). It was also shown that 
these genes are not being expressed at the late third instar ecdysone peak in the mutants 
lacking USP altogether (Hall and Thummel, 1998).  
In summary, chimeric USP mutant larvae have a phenotype similar to that seen 
with USP null mutants as well as EcRB mutant animals. While the chimera is able to 
form a functional heterodimer with EcR, interact with an ecdysone response element, and 
respond to the ecdysone agonist ponasterone A, the chimeric USP lacks some vital 
function that would enable it to develop through metamorphosis. USP null mutants 
showed a normal ecdysone inducible response during early to mid-third instar when 
ecdysone levels are low. However, both USP null and EcRB mutants are incapable of 
initiating the genetic hierarchy that is normally induced by the increasing levels of 
ecdysone just prior to pupariation.  
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Specific aims of this project 
 
 The chimeric USP is capable of performing the functions necessary for 
development through the larval stages when ecdysteroid titers are low. Based on the 
phenotypic similarity caused by EcR mutations, the dissipation of USP in the late third 
instar, and the functional failure of the chimeric USP in the late third instar- it is plausible 
to hypothesize that the chimeric USP, like the other mutants, is unable to process 20E-
induced transcriptional changes in the late third instar. On the other hand, a 
DmEcRB1/d/cUSP heterodimer can be seen on EMSA that interacts with an EcRE, 
suggesting that the metamorphic failure involves a different and unknown failure of the 
d/cUSP. Therefore, the experiments described here are intended to determine the 
capabilities of the chimeric USP for regulating ecdysteroid-inducible gene transcription. 
The first aim of this project has been to use a mammalian cell culture system to 
measure the transcriptional capabilities and differences in activity of the original chimera 
and a new chimera constructed to remove the repeat/polylinker region, along with a wild-
type DmUSP when each is tested with DmEcRA, B1 and B2. Comparisons have also 
been made between Drosophila and Chironomus USP with all three DmEcR isoforms. 
∆DBD versions of each clone were constructed to determine if there is any isoform 
specific activity such as that shown by DmUSP∆DBD with DmEcRB1 (Beatty et al., 
2006). 
The second aim will be to examine the chimeric USP in vivo in a USP mutant 
background during the late third instar to determine the effect, if any, on transcriptional 
response during third instar leading up to the arrest at late third instar. Cultured salivary 
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glands from mutants expressing the chimeric USP will be used to test the chimeric USP’s 
ability to respond to low and high doses of ecdysone as well as any possible impact on 
the normal repressive function of USP. Preliminary results from the cell culture study 
indicated that the old chimera is able to mediate a transcriptional response to 
ecdysteroids, though its repressive capabilities cannot be measured within the cell culture 
system used. 
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CHAPTER II 
MATERIALS AND METHODS 
 
 
Construction of vectors 
 
 The vectors which have been constructed for this project are shown in Figures 2 
and 3. The USP clones used in cell culture were constructed by sub-cloning the desired 
Drosophila melanogaster, Chironomous tentans, or chimeric inserts into a modified 
pVP16 vector (Clontech). The first restriction site in the multiple cloning site of pVP16 
(EcoRI) was changed to a PstI site using site directed mutagenesis. The PstI site was 
inserted at the second codon of the MCS using the following primer and its reverse 
complement: 5’-GTA CGG TGG GGA ACT GCA GGG GAT CCG TCG AC -3’ 
(underlined basepairs indicate mutations introduced). This left 9 nucleotides between the 
pVP16 AD and each insert, which were later removed with deletion mutagenesis after 
each insert was verified.  
VP16-DmUSPF2 and VP16-DmUSPF3 (Beatty, et al. 2006) also underwent 
deletion mutagenesis to remove this stuffer region using the forward primer (d/cUSP del 
F) 5’ CGA GTA CGG TGG GTG CTC TAT TTG CG 3’ and it’s reverse complement, 
and the forward primer (DmUSPIII delF) 5’ GAG TAC GGT GGG AAG CGC GAA GC 
3’ with its reverse complement. These changes to pVP16 allowed a direct transition from 
the activation domain to the DNA or ligand binding domain of each USP construct. All 
clones were made by isolating the region of interest with PCR amplification inserting it 
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into pVP16 with a PstI restriction site at the 5’ end and a HindIII restriction site at 
the 3’ end for unidirectional orientation of each insert. 
 
VP16-CtUSPII and CtUSPIII 
 The VP16-CtUSPII clone includes the Chironomous DNA binding domain 
(DBD), hinge region and ligand binding domain (LBD) from amino acids 197-553. The 
region was isolated from FpGEX-CtUSP with PCR using a forward primer (CtUSPII PstI 
DBD F) tagged with a PstI site 5’TTTT CTGCAG TGT TCT ATA TGT GGT GAT 
CGG GCT AG 3’ and a reverse primer (CtUSPII HindIII 3’ R) 5’ CGG TGG TGG TGG 
TGG AAT 3’. VP16-CtUSPIII lacks the CtUSP DBD coding only the hinge region and 
LBD (amino acids 263-553). The insert was generated using a forward primer (VP16-
CtUSPIII F) tagged with PstI 5’ TTTT CTGCAG AAG CGC GAA GCT GTG CAG 
GAA GAG 3’ and the reverse primer (New CtUSP 3’ R) 5’ GGG TCG ACT CGA GCT 
GAA GCT TAA GGA TC 3’. After an initial melting step of 10 seconds at 98°C to 
denature the template DNA, the following temperature cycles were repeated 29 times: 
98°C for 10 seconds, 60°C for 30 seconds, 72°C for 2 minutes (CtUSPII) or 1 minute 
(CtUSPIII). 
 
VP16-d/cUSPII, and VP16-d/cUSPIII  
 The insert for d/cUSP in pVP16 was isolated from pCd/cuspeR pMVZ18 (Vogtli, 
M.) using the same methods that were used for the Chironomous clones. VP16-d/cUSPII 
includes the DmUSP DBD along with a portion of the T-box (amino acids 104-178), a 
polylinker of the sequences 5’ CGA TCC CCC 3’, and an incomplete section of the 
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CtUSP T-box and LBD from amino acids 266-553. A forward primer (new VP16-
PMVZ18 F) tagged with PstI 5’ TTTT CTGCAG TGC TCT ATT TGC GGG GAT CGG 
G 3’ and a reverse primer (CtUSP3’ HindIII R) tagged with HindIII 5’ TTTT AAGCTT 
GCT TGC TGC TAC TGT CCA TCT TAA CCA TC 3’ were used to generate this insert. 
VP16-d/cUSPIII is the same as d/cUSPII with the DmUSP DBD removed; as such it 
encodes the short portion of the DmUSP T-box (amino acids 170-178), the polylinker, 
and the CtUSP LBD region from amino acids 266-553. The primers for d/cUSPIII were 
designed to remove the desired region from VP16-d/cUSPII rather than pCd/cuspeR 
pMVZ18. The forward primer (PMVZ18III newF) 5’ TTTT CTGCAG AAG CGC GAA 
GCG GTC CAG 3’ was tagged with PstI while the reverse primer (PMVZ18III R) 5’ 
CCT CTA CAA ATG TGG TAT GGC TG 3’ incorporated the HindIII site introduced in 
the construction of pMVZ18II. The PCR cycling conditions for ExTaq HS (Takara) were 
as follows: an initial 10 second denaturation step of 98°C followed by 29 cycles of 98°C 
for 10 seconds, 60°C for 30 seconds and 72°C for 2 minutes (d/cUSPII) or 1 minute 
(d/cUSPIII). 
 The PCR products from CtUSPII and III, d/cUSPII and III, and pVP16 were 
double digested with PstI and HindIII restriction enzymes to produce 5’ and 3’ sticky 
ends. The double digest reactions were incubated at 65°C for 10 minutes to denature the 
enzymes and then electrophoresed next to a 1kb+ DNA ladder on a 1% agarose gel 
treated with 1X ethidium bromide. The correct sized bands were excised from the gel and 
purified with the QiaexII gel extraction kit (Qiagen). Each insert was ligated into pVP16 
with T4 DNA ligase (New England Biolabs) at a 3:1 ratio overnight at room temperature. 
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The ligated clones were then transformed into 45µl of Ultracompetent XL10-Gold cells 
(Stratagene). The transformed cells were plated onto Luria-Bertani agarose plates 
inoculated with ampicillin at 50µg/ml. Transformed E. coli have ampicillin resistance and 
colonies form after 16 hours incubation at 37°C. Single colonies were selected and grown 
in 5ml of LB liquid media with 50µg/ml ampicillin for 8 hours at 37°C with shaking at 
250 RPM. The plasmid DNA was purified using Qiagen mini-preps, concentrations 
determined using a spectrophotometer (Eppendorf) and diagnostic digests were 
preformed with PstI and HindIII. The clones containing the correct size bands were 
sequenced using an Amersham MegaBACE and verified by alignment with DmUSP, 
CtUSP or pMVZ18 reference sequences. When the insert was verified, deletion 
mutagenesis was performed to remove the 9 base pair region between the VP16 AD and 
each insert. The forward primer (delctUSPII F) 5’ CGA GTC CGG TGG GTG TTC TAT 
ATG TGG TG 3’ and its reverse complement were used on VP16-CtUSPII. The same 
primers that were used to remove the stuffer region from VP16-DmUSPF3 were used on 
VP16-CtUSPIII and VP16-d/cUSPIII, and the same primers used on VP16-DmUSPII 
were used on VP16-d/cUSPII. Clones that showed matching sequences with no random 
mutations, insertions or deletions were then used in cell culture experiments. 
 
VP16-Dm/CtUSP (new) 
 The new chimera was constructed to have a clean fusion of the DmUSP DBD 
(amino acids 104-169) to the CtUSP hinge region and LBD (amino acids 263-553). The 
DmUSP DBD was isolated from VP16-dUSPF2 (Beatty, et al. 2006) using a forward 
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primer (DmDBD PstI F) with a 5’ PstI tag 5’ TTTT CTGCAG GCA GTG CTC TAT 
TTG CGG GGA TCG G 3’ and a blunt end reverse primer (DmDBD bluntR) 5’ CAT 
GCC GCA GGT TAG GCA CTT C 3’. The CtUSP LBD was generated using a blunt end 
forward primer (CtLBD blunt F) 5’ AAG CGC GAA GCT GTG CAG GAA GAG AG 3’ 
and the reverse primer (ctUSP HindIII R) used with VP16-CtUSPII and CtUSPIII. The 
PCR conditions using Primestar polymerase for DmDBD were as stated above with a 30 
second extension time for DmDBD and a 2 minute extension time for CtLBD. The two 
PCR products were gel purified using the protocol elucidated above and a blunt end 
ligation was performed. The ligation products were electrophoresed on a 1% agarose gel 
with 1X ethidium bromide after incubating overnight at room temperature. The 
appropriate band was gel purified and then amplified using PCR with the forward primer 
used in the DmDBD isolation and the reverse primer used in the CtLBD isolation. The 
Dm/Ct USP insert was digested with PstI and HindIII and the same ligation and 
transformation procedure was followed as stated above with the VP16-CtUSP and 
d/cUSP clones.  
Following sequence verification the VP16-Dm/CtUSP clone was found to have 2 
missing base pairs between the DmDBD and CtLBD. Rather than repeating the procedure 
above, insertion mutagenesis primers were designed to reinsert the missing base pairs. 
The following forward primer and its reverse complement were used (d/cUSP4 
insertionF/R) 5’ CTA ACC TGC GGC ATG AAG CGC GAA GCT 3’ with the 
underlined region indicating the base pairs inserted. After sequencing to verify the 
insertion mutagenesis was successful and no other random mutations had occurred, 
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deletion mutagenesis was performed to remove the 9 base pair stuffer region between the 
VP16 AD and the Dm/CtUSP insert with the following primer and its reverse 
compliment: (del d/cUSP F/R) 5’ CGA GTA CGG TGG GTG CTC TAT TTG CG 3’. 
Again the clone was sequenced to verify that the stuffer region had been removed with no 
other mutations introduced.  
 
New chimera in fly vector 
 See Appendix A 
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Figure 2. Schematic diagrams of the USP inserts for cell culture constructs in the VP16 
vector. VP16-DmUSPII and III from Beatty et al.,2006. Shades of blue represent a 
Drosophila domain, while shades of red represent Chiromonus. A dashed line indicates a 
USPIII construct which does not contain a DBD. Yellow boxes illustrate the position of 
primers used to amplify each region. 
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pCasper4-dm/ctUSP 
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(from Henrich et al., 
2000) 
pCasper4 vector 
Native Drosophila USP promoter 
5’  untranslated region (UTR) 
Drosophila A/B/C domains 
Chironomus E domain 
Figure 3. Schematic diagrams of the chimeric USP constructs in fly transformation 
vectors. pMVZ18 is the original plasmid used in  usp mutant larval rescue studies 
(Henrich et al., 2000). pCasper4-dm/ctUSP cloning was not completed (see Appendix 
A). 
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Cell culture 
 A mammalian cell culture system was used in this study to compare the activity of 
both the old and new chimera with the wild-type DmUSP. Chinese hamster ovary (CHO) 
cells were co-transfected with pVP16-DmUSPII and III, VP16-CtUSPII and III, d/cUSP 
II and III or the new chimera (Dm/CtUSP) along with pcDNA3-DmEcRA, B1 or B2. The 
cells were also transfected with a luciferase reporter plasmid (pEcRE tk-LUC) containing 
the hsp27 ecdysteroid response element in its promoter. The transcribed USP and EcR 
proteins form a heterodimer that interacts with the response element affecting the 
transcription of the luciferase gene. The pCH111 β-galactosidase plasmid was also 
introduced and its constitutive activity was used as a measure of transfection efficiency 
and as a means of normalizing the luciferase activity.  
 The CHO cells were grown in 15ml of Dulbecco’s Modified Eagle’s Medium 
(DMEM/F-12, Gibco) with 5% fetal bovine serum (FBS, MP Biomedicals, Inc.) in a 75 
cm2 cell culture flask. The cells were allowed to grow to confluence in a 37°C water-
jacketed incubator with a 5% CO2 atmosphere. At confluence the cells were prepared for 
seeding 6-well plates by aspirating the media with a sterile Pasteur pipette within a 
laminar flow hood. After the removal of the media 3ml of 1X trypsin was added to the 
flask and allowed to sit for approximately 30 seconds. The trypsin was then removed 
with care so as not to disturb the cell layer. 5ml of DMEM/F-12 5% FBS was used to 
separate the cells from the bottom of the flask and resuspend them with out aeration. The 
cells were transferred to a sterile 14ml Falcon tube and 10µl were removed and added to 
90µl Trypan Blue to determine their concentration with a hemocytometer. The plates 
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were seeded with 3.0x105 cells per well in 2ml DMEM/F-12 5% FBS after pooling in a 
50ml tube to insure a consistent density of cells in each well. After 24 hour incubation at 
37°C at 5% CO2 the cells have grown to about 75% confluence which is the appropriate 
density for transfection. 
 The cells were co-transfected with pEcRE-tk-LUC, pCHIII, one of the pVP16-
USP clones and either pcDNA3-DmEcRA, B1, B2 or CtEcR. Following a 4 hour 
incubation period the cells were treated with hormone. The treatments were: no hormone, 
muristerone A (Alexis Corporation, San Diego, CA), JHIII (Sigma, St. Louis, MO), or 
murA + JHIII. Initial tests were performed at 0 and 1.0 µM murA with all USP clones 
and DmEcR A, B1, and B2. A dose response experiment was performed with old and 
new chimera with DmEcR B1 with the following treatment: 
0 µM murA 
0.1 µM murA 
0.5 µM murA 
1.0 µM murA 
2.5 µM murA 
5.0 µM murA 
 The old and new chimera were also tested for potentiation with DmEcR B1 with 
the following hormone treatment: 
0 µM murA 
0.1 µM murA 
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1.0 µM murA 
0.1 µM murA + 80 µM JHIII 
80 µM JHIII 
 
 24 hours after hormone treatment the cells were harvested, lysed, and assays were 
performed on the cell extracts. The luciferase activity was measured in a luminometer. 
The β-galactosidase assay, measured by absorbance at 420nm, was done in duplicate and 
the average per sample was used to normalize luciferase activity. 
 
Western blot analysis 
 
 Western blots were performed on CHO cell culture extracts based on the β-
galactosidase activity in the assay described above. The extracts were electrophoresed on 
a 12% polyacrylamide gel at 150V after which the gel was electroblotted (Mini Trans 
Blot Module, Bio Rad) on a 0.2µm  polyvinylidene difluoride (PVDF) membrane 
(Immun-Star, Bio Rad) at 300mA. The membrane was soaked in blocking buffer (3% 
w/v milk powder, 10mM Tris-HCl, 150mM NaCl, 1% v/v NaN3, 0.1% v/v Tween 20, pH 
7.6) for 4 to 6 hours. The USP constructs were detected using the VP16 monoclonal 
mouse IgG antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) that recognizes an 
N-terminal sequence of VP16 (aa 411-456). The antibody was added at a 1:200 dilution 
factor in the blocking buffer. A peroxidase-conjugated secondary antibody (goat anti-
mouse IgG) diluted 1:1000 (10mM Tris-HCl, 150mM NaCl, 1% v/v NaN3, 0.1% v/v 
Tween 20, pH 7.6) was used to detect specific Western signals. The membrane was 
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incubated in chemiluminescent solution (Biorad) and the image was developed using the 
Biorad chemiluminescent system. 
 
Drosophila stocks 
 
 The chimeric USP construct [yw; 71D/71D] (Henrich et al., 2000) was used to 
rescue usp4 mutants [FM7/yusp4w] through early larval lethality. Crosses were raised on 
standard cornmeal agarose food with the addition of 0.5% bromophenol blue (Sigma, St. 
Louis, MO), and turned over every 24 hours to maintain a relatively constant supply of 
emerging larvae. Mutant larvae were determined as males by brown mouthhooks caused 
by the X-linked mutation, yellow, and closely linked with the recessive lethal usp4 
mutation. Wild-type male and female siblings with black mouthhooks were used as 
controls. Larval stage was established by the amount of food left in the gut after the 
larvae ceased feeding and began to wander (Andres and Thummel, 1994). Correctly 
staged animals had reached third instar size, were still within the food, and had not begun 
clearing their guts. The excised glands were thinner, slightly shorter than late third instar 
glands, and had a ‘grape cluster’ appearance with rounded cell membranes visible along 
the outside of the gland.  
 
Salivary gland analysis 
 
 Paired glands of mutant and control animals were extracted and incubated for one 
hour in 100 µl Schneider’s media (Invitrogen) removing and replacing 50µL of media 
every 20 minutes. The glands were then separated and placed in a 10µl hanging drop in 
the lid of a 0.5ml centrifuge tube. One gland of each pair was left untreated while the 
 26 
second gland was treated with either 100nM or 5µM 20E. The hanging drops were 
incubated at 25°C for 2 hours after which total RNA was purified using the Qiagen 
RNeasy Micro kit and protocol. 
 RT-PCR was performed on extracted RNA using the Qiagen OneStep RT-PCR 
kit and protocol. Salivary gland extracts were tested for expression of the following 
genes: rp49 (forward primer 5’ GTG TAT TCC GAC CAC GTT ACA 3’, reverse primer 
5’ TCC TAC CAG CTT CAA GAT CAC 3’), sgs-3 (forward primer 5’ TGC ATG GAG 
GTT GCG TGG TAG ATT 3’, reverse primer 5’ ATG AAG CTG ACC ATT GCT ACC 
GCC CTA 3’), E74A (forward primer 5’ CGG ACT TGT CGA TTG CTT GA 3’, reverse 
primer 5’ AAG CTG GAG TAC GCC CTC AT 3’), E74B (forward primer same as 
E74A, reverse primer 5’ TAC TCC GGC ACG GAA TCC GA 3’), and BR-C Z1 
(forward primer 5’ CCG AGG TGT TCA ATG TTG AG 3’, reverse primer 5’ AAC 
ACA CAG TTG CAG CAG TC 3’) (Huet et al., 2003). RT-PCR products were 
electrophoresed on a 1.4% agarose gel and electronic images were analyzed in Quantity 
One software (BioRad). The density of each band was quantified and normalized relative 
to the rp49 values. The expression levels of E74A, E74B and BRC-Z1 were reported as 
percentages of rp49 expression. 
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CHAPTER III 
RESULTS 
 
 
Cell culture 
 
 A heterologous cell culture system was used to examine the transcriptional 
capabilities of modified USP constructs with Drosophila EcR (Beatty et al., 2006; 2009). 
This system is useful for assessing the ability of a mutated receptor to respond to 
ecdysteroids, interact with a response element and activate transcription in comparison to 
a wild-type EcR/USP heterodimer. In this series of experiments, the USPII versions 
contain the VP16 activation domain with the Drosophila DBD and either the DmLBD or 
Chironomus LBD. The old chimera contains the repeat/polylinker region described 
previously, while the new chimera (VP16-Dm/CtUSPII) has a direct transition from the 
DmDBD to the CtLBD. The repeat/polylinker region was removed to rule out the 
possibility that the lethal phenotype seen with the USP chimera in vivo was the result of 
this additional sequence. The USPIII plasmids are lacking the DBD.  
 
Dose response with old and new chimera 
 
 The old and new chimera were tested alongside DmUSPII with DmEcRB1 and 
subjected to increasing doses of muristerone A in CHO cells. The basal and induced 
activity of the old d/cUSP chimera (analogous to the transformation vector used 
previously in flies) was consistently higher than that of DmUSPII. The new chimera, 
which lacks the artifactual duplication which was found in the old chimera, showed 
 28 
higher levels of activity than both DmUSPII and the old chimera except with a dose of 
0.1 µM where the old and new chimera had a similar level of induction (Figure 4). 
DrosophilaEcR/Drosophila USP reached maximal levels of activity at 0.5µM murA, 
while EcR with the old and new chimera both showed maximal levels at 1.0µM murA. 
However, the actual level of induction at 0.5µM murA was about the same for all USP 
constructs. 
 
Juvenile hormone potentiation 
When the old and new chimera were tested for juvenile hormone potentiation with 
DmEcRB1, a similar pattern emerged. Both old and new Dm/CtUSP chimeras showed 
greater response to murA than DmUSPII. The old chimera and DmUSPII showed the 
same level of potentiation with addition of JHIII to 0.1 µM murA, while the new chimera 
showed an even higher level of potentiation (Figure 5). The activity of all three USP 
constructs was at basal levels with the addition of JHIII alone. 
 
Activity of USP constructs with DmEcR isoforms 
 
 All of the VP16-USPII (DmUSP, CtUSP, d/cUSP (old) and d/cUSP (new)) were 
tested with each of the three Drosophila EcR isoforms. The results from DmEcRB1 with 
DmUSPII, and both chimeras agreed with earlier experiments (Figures 4 and 6a). The 
new chimera’s ecdysteroid induced activity was higher than that of the old chimera, 
which was higher than that of DmUSPII. The same trend was seen with these clones 
when co-transfected with DmEcRA. However, the old chimera showed much lower 
activity with DmEcRB2 than DmUSPII while the new chimera’s activity was higher than 
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the old chimera and similar to that of DmUSPII (Figure 6a ). Chironomus USP showed 
similar levels of activity as DmUSP with DmEcR A, but with the DmEcR B isoforms 
CtUSP activity was much lower than DmUSP and also lower than both of the chimeric 
USPs (Figure 6a).  
The Drosophila ∆DBD USP (DmUSPIII) shows isoform specific behavior with 
little or no activity when co-transfected with DmEcRA or B2, but an increase in activity 
with DmEcRB1 that was previously identified (Beatty et al., 2006). Unlike the behavior 
of DmUSP, neither of the other Chironomus ∆DBD clones (CtUSPIII and d/cUSPIII) 
showed inducible activity with DmEcRB1 (Figure 6b, center set). However, it is evident 
that CtUSPIII and the ∆DBD version of the old chimera showed slightly higher levels of 
activity with DmEcRB1 than they did with DmEcRA or B2 (Figure 6b). They also 
showed some inductive capability, but very little when compared to DmUSPIII. 
 
Western blot 
In order to verify the expression of the VP16-USP constructs in CHO cells, 
immunoblotting was performed with a VP16 mouse monoclonal antibody that recognizes 
amino acids 410-456 in the VP16 A/B domain. This is especially important for the 
∆DBD Chironomus constructs that showed little or no activity with any of the DmEcR 
isoforms (Figure 6b). Levels of DmUSPII and DmUSPIII (∆DBD) agreed with those seen 
in a previous study (Beatty et al., 2006), and the old and new chimeric USP constructs 
both showed a strong signal (Figure 7). The CtUSPII construct was present at slightly 
lower levels, even though its measured transcriptional activity with DmEcRA and B1 was 
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comparable to that of DmUSPII (Figure 6a). The CtUSPIII (∆DBD) protein also 
presented a strong signal, while the ∆DBD version of the old chimera showed the lowest 
expression levels of all the constructs. The low levels of old chimera III expression 
complicate the interpretation of its transcriptional activity. Nevertheless, the high 
expression levels of CtUSPIII indicate that the failure to form an active dimer with 
DmEcR B1 arises from a functional difference in the LBD of CtUSP compared to that of 
DmUSP. 
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Figure 4. Dose response with muristerone A (murA) from 0-5µM in Chinese hamster 
ovary (CHO) cells co-transfected with pcDNA3-DmEcRB1, VP16-DmUSPII 
(unshaded), VP16-d/cUSPII (gray), and VP16-Dm/CtUSP (black). Fold induction 
measured as relative luciferase units normalized to β-galactosidase levels with 
DmEcRB2/DmUSPII at 0µM murA as 1 (not shown).  
Figure 5. Juvenile Hormone III (JHIII) potentiation by USP constructs and DmEcRB1 
with murA at 0µM, 0.1µM and 1.0µM. CHO cells were co-transfected with pcDNA3-
DmEcRB1 and VP16-DmUSPII (unshaded), VP16-d/cUSPII (gray), and VP16-
Dm/CtUSP (black). VP16-d/cUSPII construct includes polylinker repeat region. VP16-
Dm/CtUSP is a clean fusion between Drosophila DBD and Chironomus D domain and 
LBD. 
 32 
 
Figure 6. Transcriptional activity of VP16-USP constructs.  
(a). USPII constructs are composed of the VP16 A/B domain with Drosophila 
and/or Chironomus DBD and LBD. The plasmids were co-transfected with DmEcRA, 
DmEcRB1, and DmEcRB2. Open bars indicated basal activity while closed bars represent 
induced activity with 0.1µM murA. 
 (b). Transcriptional activity of VP16-USPIII (∆DBD) constructs co-transfected with 
all three DmEcR isoforms. Drosophila and Chironomus USP proteins lacking a DBD 
showed little or no activity with DmEcR with the notable exception of VP16-DmUSPIII 
with DmEcRB1. 
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Figure 7. Western blots of Drosophila, Chironomus, and chimeric USP contructs 
from the extracts of transfected CHO cells. Immunoblotting was performed with a 
VP16 mouse monoclonal antibody (Santa Cruz Biotechnology) that recognizes a 
region within A/B domain of VP16 present in all the VP16-USP constructs. The 
image on the left contains the signals of VP16-DmUSPII and -DmUSPIII, while 
the image on the right showsVP16-CtUSPII and -CtUSPIII (lanes 1 and 2), the old 
and new versions of the chimeric USP (lanes 3 and 5), and the ∆DBD version of 
the old chimera (lane 4). 
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In vivo response to 20E 
In order to test the ability of the chimeric USP to mediate ecdysteroid responsive 
transcriptional activity, it was tested in vivo for its ability to induce gene expression in the 
larval salivary gland. Salivary glands were dissected in pairs from either mutant or 
control animals. One gland from each pair was treated with a high (5µM) or low (100nM) 
dose of 20E, and then tested for transcriptional response to hormone. The other member 
of the pair was used as a control and incubated with no hormone. The constitutively 
active rp49 was used as an internal control for the RT-PCR, and the expression of the 
early low-dose responsive gene E74B, the early high-dose response gene E74A, along 
with BRC-Z1 was measured relative to rp49 levels. 
 
Low dose response 
 
 At 100nM, the late gene E74A shows no response to ecdysone in either the 
mutant or control animals (Figure 8 (left); Figure 9 (upper)). E74B responds to the low 
dose of 20E by showing a 2 to 3 fold increase in expression compared to the untreated 
glands in both mutant and control. BRC-Z1, a gene which is activated by de-repression in 
usp mutant tissues, has little or no activity in the untreated glands and a normal response 
to ecdysone as compared to the control response. In other words, there are no indications 
that the chimeric USP is unable to repress BRC-Z1 expression in the absence of 
hormone. 
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High dose response 
 
 When glands were cultured with 5µM 20E, the mutant animals again showed a 
normal ecdysone mediated response. The expression of E74A was about 15 fold higher in 
treated glands than untreated ones in both mutant and control animals (Figure 8 (right); 
Figure 9 (lower)). While E74A expression levels rose, the expression of the early gene 
E74B decreased by half in mutant and control glands, indicating normal capabilities in 
both cases. BRC-Z1 expression, as seen in the low dose experiments, responded normally 
to 20E in mutant animals by showing little or no activity in untreated glands and 
increasing to levels comparable to wild-type with treatment. 
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Wild-type Mutant 
Low dose response 
  rp49 E74A E74B   rp49 E74A E74B 
0nM 20E 
100nM 20E 
0nM 20E 
100nM 20E 
0nM 20E 
100nM 20E 
Wild-type Mutant 
High dose response 
  rp49 E74A E74B   rp49 E74A E74B 
0µM 20E 
5µM 20E 
0µM 20E 
5µM 20E 
0µM 20E 
5µM 20E 
Figure 9. Ecdysteroid-induced response of E74A and E74B at high (5µM) and low 
(100nM) 20E concentrations.  Paired salivary gland experimental technique as 
described in Figure 8. Low dose response (upper) shows ecdysone-induced expression 
of E74B with no response in E74A. High dose response (lower) shows activation of 
E74A while E74B expression remains the same or decreases. A constitutively 
expressed gene (rp49) was used as an internal control and to normalize the quantified 
density of each band (data shown in Figure 8) and is placed on the left of each 
experimental set. 
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CHAPTER IV 
DISCUSSION 
 
 This study examined the capability of a Drosophila/Chironomus USP chimera to 
mediate ecdysteroid-inducible response in both a mammalian cell culture system and in 
vivo. The chimeric USP showed comparable basal and murA induced transcriptional 
activity to DmUSP when co-transfected in CHO cells with each of the three DmEcR 
isoforms. The d/cUSP/DmEcRB1 heterodimer also showed the same level of potentiation 
as DmUSP/DmEcRB1 when treated with JHIII. In other words, these results reveal no 
impairment of ecdysteroid response attributable to the chimeric USP within the scope of 
the cell culture system.  
 The chimeric USP was then examined in vivo using two classic examples of 
ecdysteroid receptor mediated response; the E74 gene which functions under alternate 
promoters inducing a high and low sensitivity response, and BRC-Z1 which is an isoform 
of a complex gene that has been shown to be active through de-repression in the presence 
of 20E. De-repression occurs prematurely in usp mutant tissues, indicating a possible 
functional failure involving USP mutants. For both genes, the expression patterns from 
salivary glands extracted from d/cusp mutant animals were indistinguishable from those 
seen in wild type. The chimeric USP is capable of mediating ecdysteroid response at both 
low and high titers, and does not interfere with the repression of BRC-Z1 in the absence 
of hormone.  
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Although this evidence indicates that the chimeric USP is able to function with DmEcR 
in ecdysteroid-induced regulation, the fact still remains that d/cusp mutant flies are 
unable to develop normally beyond the larval stages. The mammalian cell culture system 
is a valuable tool for EcR/USP analysis that allows a close examination of an altered 
ecdysteroid receptor’s ability to activate transcription in the presence and absence of 
hormone. A large number of mutated receptors can be examined relatively quickly and 
any deviations from normal transcriptional activity can be directly attributed to the 
mutation. However, only a single type of EcRE was tested in this study and it is possible 
that the use of alternate response elements known to be active with EcR and USP (Vogtli, 
et al., 1998) in the reporter gene system in cell culture would reveal a functional 
abnormality in d/cUSP.  
 While examining a modified receptor in a cell culture system has the advantages 
of testing a receptor in the absence of known comodulators that could affect in vivo 
activity, it is most useful as a means of predicting the effect of mutations to the receptor 
in vivo. In this case, the activity of d/cUSP in vitro suggested it was capable of hormone-
induced transcriptional activation. This was borne out with E74 and BRC-Z1 in the 
salivary gland. However, E74 and BRC-Z1 are just two examples among hundreds of 
genes regulated by the fluctuating levels of 20E in developing larvae (Guahar et al., 
2009). Testing a wider range of ecdysteroid-inducible genes may lead to the 
identification of the malfunction or malfunctions caused by the chimeric USP that lead to 
late larval arrest. 
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This study also focused on the ability of the chimeric receptor to mediate 20E 
regulation only in the salivary gland, a tissue that predominantly expresses EcRB1 
(Talbot et al., 1993). The methods described in this study for salivary gland dissection 
and hormone treatment could also be used to analyze other tissue types that undergo 
different genetic changes in response to 20E, most notably the differences between larval 
tissues that eventually degenerate, and proliferating tissues that will form adult structures, 
particularly the imaginal discs. 
 As mentioned above, the in vitro transcriptional activity of the full length 
chimeric USP was comparable to that of DmUSP with all three DmEcR isoforms when 
tested in cell culture. The ∆DBD constructs, on the other hand, revealed a notable 
difference in activity with DmEcRB1 that is attributable to the CtLBD. As with 
DmUSP∆DBD, the ∆DBD versions of CtUSP and the chimeric USP were unable to 
activate transcription in the presence of hormone with either EcRA or B2. DmUSP∆DBD 
has been shown to activate transcription with EcRB1 (Beatty et al., 2006), but the 
Chironomus and chimeric ∆DBD USP constructs were unable to do so. This suggests that 
there is some difference between the LBD region of USP and the d/cUSP that is 
responsible for this alternate behavior. The major distinction between the two USP 
sequences are two glycine rich regions before helix 1 and a β-sheet loop between helices 
5 and 6, which so far are unique to DmUSP. Interestingly, this indication of a difference 
in function between d/cUSP and EcRB1 seen in the cell culture experiments parallels the 
phenotypic similarities between EcRB1 mutants and the chimeric USP mutants. The 
chimeric USP is able to rescue usp mutant animals through the larval stages, but is unable 
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to perform some function necessary for metamorphosis. In the same way, EcR null 
mutants die during embryogenesis, but EcRB1 mutants are able to develop through the 
larval stages and fail at metamorphosis (Bender et al., 1997). Both the chimeric USP and 
EcRB1 mutant larvae at late third instar fail to wander, evert their anterior spiracles or 
contract, and both have abnormal cuticle development. However, an important distinction 
arises when comparing ecdysteroid-inducible response in the salivary glands. In the 
EcRB1 mutants puff response was tested and showed an elimination or significant 
reduction of early and early-late puffs, while RT-PCR analysis of early (E74B and BRC-
Z1) and early-late (E74A) gene expression in d/cusp mutants showed no deviation from 
wild type. 
 A more thorough histological analysis could further elucidate the potential causes 
of late larval arrest in the d/cUSP mutants. It has already been shown that the chimeric 
USP mutants share some phenotypic similarities with USP null and EcRB1 mutants. It 
would be useful to examine the different tissue types during mid- and late-third d/cusp 
mutant larval to determine if the proliferation of adult tissues is correctly timed and 
organized, and if larval tissues are degenerating normally.  
Mutants with blocked farnesoid synthesis share some phenotypic similarities with 
USP null mutants, such as the presence of extra mouthhooks and a double cuticle in the 
larval stages. The farnesoid-defficient mutant late third instar larvae also show abnormal 
wandering behavior and often fail to wander off the food as is seen with d/cusp mutants. 
In addition, farnesoid-defficient mutants do not fully contract prior to pupariation (Jones 
et al., 2009). This is a chimeric USP mutant phenotype that persists even in animals that 
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have been rescued through adulthood with multiple doses of d/cusp (Henrich et al., 
2000). 
 It will also be important to determine which region or regions of the CtLBD are 
responsible for the developmental failure prior to metamorphosis. An efficient strategy 
would involve creating VP16 constructs with smaller chimeric regions of the CtLBD or 
point mutations and screening them in the cell culture system. If any of these new USP 
chimeras showed differences in transcriptional capabilities compared to the original 
chimera, they could be used in usp mutant rescue studies to determine if they salvage 
USP function through metamorphosis.   
 The ability of the chimeric USP to function properly through larval development, 
but fail at metamorphosis illustrates that amino acid sequence similarity between nuclear 
receptor homologs does not guarantee evolutionary conservation of function. However, 
these differences in activity caused by minor variations in sequence can be used to 
analyze the function of individual receptor domains within a relatively simple model 
organism. Functional capabilities of DmEcR/USP revealed with this system can be used 
to extrapolate potential function of other members of this highly conserved family of 
proteins in more complex organisms.  
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Appendix A. 
 
NEW CHIMERA IN FLY TRANSFORMATION VECTOR 
 
 The following strategies were employed in an attempt to construct a 
Drosophila/Chironomus chimeric USP with a clean transition from the Drosophila DBD 
through the Chironomus LBD, all of which were ultimately unsuccessful.  
 
I. pVP16-d/cUSP transfer to fly transformation vector 
 
 The original chimeric USP (pMVZ18) is in a modified pCasper4 vector under the 
control of the native Drosophila USP promoter. The first strategy was designed to 
remove the clean chimeric region already constructed in the cell culture vector pVP16 
and transfer the discrete region into pMVZ18, replacing the repeat/polylinker region 
present in the old chimera. The pMVZ18 construct is a large plasmid (13.3kb), and while 
a unique restriction site (PacI) was found in the ctLBD, no viable unique site was present 
in the dmDBD. As such, it became necessary to introduce a unique restriction site using 
site-directed mutagenesis. The following primers were used to mutate two nucleotides 
and introduce an Mlu I restriction site to the dmDBD pVP16-d/cUSP and pMVZ18 
(primer forward 5’ GGA TCT CAC ATA CGC GTG CAG GGA CTG C 3’ and its 
reverse compliment). At the same time mutagenesis primers were designed to remove the 
Mlu I site upon the transfer of the chimeric fragment. While the site-directed mutagenesis 
was successfully completed on the pVP16-d/cUSP construct, and the chimeric fragment 
was isolated by a double digest with Mlu I and Pac I, the mutagenesis was unsuccessful 
on pMVZ18. After several attempts this strategy was abandoned.  
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II. Deletion mutagenesis with megaoligo primers 
 
 New primers were designed to flank the repeat polylinker region in pMVZ18, 
removing the 30 base pair fragment 5’ GCG GTC CAG GAG GAG CGT CGA TCC 
CCC GAA 3’ using a modified deletion mutagenesis protocol with a two step PCR 
process (Wang and Malcolm, 1999). The deletion primers (primer forward 5’ CCT GCG 
GCA TGA AGC GCG AAG CTG TGC AGG AAG AGA GGC 3’ along with its reverse 
compliment) were used in a preliminary single primer extension reaction with a 30 
second initial denaturation step at 95°C followed by 10 cycles of: 95°C for 30 seconds, 
55°C for 15minutes and 68°C for 8 minutes. After which 25µL of each single primer 
reaction were combined and cycled under normal mutagenesis cycling conditions (Quik-
Change Mutagenesis, Stratagene). Multiple attempts were made to optimize both the 
single primer extension step and the second standard amplification step without success. 
 
III. Amplification away from repeat/polylinker and re-circularization 
 
 Again using pMVZ18 as a template, primers were designed flanking the 
repeat/polylinker region with a reverse primer (5’ GCG CTT CAT GCC GCA GTT TA 
3’) at the 3’ end of the dmDBD and a forward primer (5’ GAA GCT GTG CAG GAA 
GAG AGG CA 3’) at the 5’ end of the ctLBD. These primers would amplify away from 
the repeat region theoretically resulting in an open plasmid, without the repeat/polylinker, 
that could be re-circularized into a pMVZ18 construct with a clean transition between the 
dmDBD and ctLBD. Difficulties optimizing the PCR cycling conditions led to excessive 
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non-specific amplification and insufficient PCR product available for the subsequent 
circularization step. 
 
IV. Isolation and ligation of dmUSP 5’UTR-DBD and ctUSP LBD 
 
 Employing a strategy similar to that which led to the successful construction of 
the new chimera in the pVP16 cell culture vector, the next attempt involved the 
amplification of the dmUSP 5’ untranslated region through it’s DBD along with the 
separate amplification of the ctUSP LBD. Both of these regions would be blunt ligated 
and then re-amplified to select for those fragments in the correct orientation (see 
Materials and Methods VP16-Dm/CtUSP (new)). Rather than return to using pMVZ18 as 
a template, p5’usp1B was used instead. This plasmid contains the Drosophila 5’ UTR 
region through the DBD and is much smaller (7.4kb) than pMVZ18, potentially making it 
easier to work with. The forward primer (5’ TTC GCC AAA TAG CAC AGA GAA 
TGC G 3’) was used in conjunction with the same reverse primer that was used in the 
VP16-Dm/CtUSP strategy mentioned above. The primers used to isolate the ctUSP LBD 
were also the same. A 4.3kb dmUSP fragment was amplified from p5’usp1B and purified 
as was the 1.1kb ctUSP LBD fragment. A blunt ligation was performed and the resulting 
5.4kb fragment was gel purified and re-amplified using the forward dmUSP primer and 
the reverse ctUSP LBD primer. It was then attempted to blunt ligate the fragment into a 
pCasper4 vector. Multiple attempts of blunt ligation were unsuccessful, and the next 
strategy was to use restriction sites (5’ EcoRI and 3’ KpnI) inherent in the 5’ and 3’ 
regions of the chimeric fragment. As there is an EcoRI site approximately 15bp from the 
stop codon in the ctUSP LBD, the dmUSP and ctUSP fragments had to be digested 
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separately before the blunt ligation/re-amplification described above. At the same time a 
modified strategy was attempted using the two digested fragments and pCasper4 digested 
with EcoRI and KpnI in a 3-way sticky-blunt-sticky ligation. Both of these strategies 
failed initially, and due to time constraints were unable to be further pursued. 
